ABOUT US

Executive Team

Patric Stenberg
Chief Executive Officer

Experience
Patric Stenberg (born 1970) is one of the co-founders of Gesynta Pharma. He holds a PhD in Pharmaceutics from Uppsala University. Patric has more than 20 years of experience from positions as CEO, Chief Scientific Officer, business development manager and pharmaceutical R&D scientist within the life science industry, ranging from small virtual organizations to global pharma companies.

Other assignments
Board Director of Capensa AB

Charlotte Edenius
VP R&D Strategy

Experience
Charlotte Edenius (born 1958), M.D, Ph.D., is one of the co-founders of Gesynta Pharma. Charlotte has 30 years of experience from positions within the life science industry with experience from all phases of drug development as well as business development including successful partnering and licensing. Her experience spans from AstraZeneca to biotech companies including senior management positions as EVP R&D, Medivir AB, SVP Research, Orexo AB, and CSO, Biolipox AB. Charlotte has also served in non-executive board positions in several private and public pharma companies, including Karolinska Development AB and Immunicum AB. 

Other assignments
Board Director of Kancera AB (publ)
Chairman of the Board and CEO of Allmora Life Science AB

Gunilla Ekström
VP Project Management

Experience
Gunilla Ekström (born 1958) is one of the co-founders of Gesynta Pharma. She holds an MD, PhD and associate professorship from Karolinska Institutet. Gunilla has more than 30 years of experience from the pharmaceutical industry including all stages of drug development, from discovery to registration. Her previous roles include senior management positions at AstraZeneca, Orexo and Karolinska Development. Further, she has served as CEO in several smaller companies. Gunilla has also served as non-executive director in several pharma companies, such as NovaSAID.

Other assignments
Board Director of Corline Biomedical AB, Disruptive Pharma AB, Initiator Pharma A/S, MyCural AB and Strike Pharma AB

Michaela Gertz
Chief Financial Officer

Experience
Michaela Gertz (born 1981) holds an MSc in Business and Economics from Uppsala University. She has more than 15 years of experience from positions as CFO, Investor Relations Manager and Head of Investor Relations & Financing in several life science companies listed on Nasdaq Stockholm. 

Other assignments
Board Director of Codemill AB (publ)

Eva Johnsson
Chief Medical Officer (CMO) and VP Clinical Development

Experience
Eva Johnsson (born 1963), holds an M.D, Ph.D., and associate professorship from Gothenburg University. With 25 years of executive leadership experience in major pharmaceutical companies as well as the startup world, Eva has worked in clinical drug development and medical affairs, including regulatory approvals and drug commercialization, and has also engaged in business development and strategy and project management. She has held several senior roles with global clinical responsibility and has had positions in inflammation and pain as well as other therapeutic areas at Grünenthal, AstraZeneca, and BASF Pharma AG/Knoll Läkemedel AB.

Learn more about Gesynta Pharma

Gesynta Pharma bases its R&D on groundbreaking research from the Karolinska Institutet.

The members of Gesynta Pharma's management team and board of directors have extensive experience from drug development and commercialization.

Endometriosis is a chronic, inflammatory, estrogen-dependent disease affecting millions of women worldwide.

Our lead drug candidate vipoglanstat is in clinical phase II for endometriosis, while GS-073 is ready to enter clinical phase I for chronic inflammatory pain.